Skip to main content

Integer Holdings Corporation (ITGR) Stock Analysis

Range Bound setup

Buy WaitVALUE-TRAP 3/5Moderate Confidence

Healthcare · Medical Devices

Earnings in 0 days (2026-04-30). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait for pullback to $72.55. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $87.78. Engine's entry $72.55 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Value-trap signals (3/5): Revenue declining (-89.9% YoY), Margin compression (op margin -6710.7%), Negative free cash flow.

Integer Holdings is a leading medical device CDMO serving Cardio & Vascular, Neuromodulation, and Cardiac Rhythm Management markets under the Greatbatch Medical and Lake Region Medical brands. It sells components, subassemblies, and finished devices primarily to large... Read more

$87.78+13.4% A.UpsideScore 5.2/10#29 of 40 Medical Devices
Entry $72.55(Support Atr Sticky)Stop $66.05Target $89.25(resistance)A.R:R -0.6:1Setup A.R:R 2.7:1
Analyst target$93.25+6.2%8 analysts
$89.25our TP
$87.78price
$93.25mean
$84
$101

Wait for pullback to $72.55. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $87.78. Engine's entry $72.55 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Value-trap signals (3/5): Revenue declining (-89.9% YoY), Margin compression (op margin -6710.7%), Negative free cash flow. Chart setup: RSI 57 mid-range, Bollinger mid-band. Earnings in 0 days. Wait until post-earnings. Score 5.2/10, moderate confidence.

Passes 3/7 gates (clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA) and earnings proximity 0d<=7d. Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
Analyst target reached - limited upside remaining
Value-trap signals (3/5): Revenue declining (-89.9% YoY), Margin compression (op margin -6710.7%), Negative free cash flow

Key Metrics

P/E (TTM)29.0
P/E (Fwd)11.6
Mkt Cap$2.9B
EV/EBITDA11.1
Profit Mgn5.5%
ROE6.1%
Rev Growth5.0%
Beta0.71
DividendNone
Rating analysts17

Quality Signals

Piotroski F8/9

Options Flow

P/C7.23bearish
IV71%elevated
Max Pain$70-20.3% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMCustomertop three customers49%
    10-K Item 1A: 'In 2025, our top three customers collectively accounted for approximately 49% of our revenues.'

Material Events(8-K, last 90d)

  • 2026-03-12Item 5.02LOW
    Board to add James F. Flanagan and investor-designated Aaron Kapito per Cooperation Agreement with Irenic Capital signed March 9, 2026. Two incumbent directors will not stand for re-election at 2026 Annual Meeting. Board composition change, no officer departure.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
2.8
Quality Rank
4.7
Value Rank
5.3

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Obv
1.0
Rsi
4.5
Ma Position
6.0
Volume
6.3
Volume distribution (falling OBV)Below 200-MA, MA slope -5.3%/30d — confirmed downtrend
GatesMomentum 3.6<4.5A.R:R -0.6=NEGATIVEDeath cross (50MA < 200MA)EARNINGS PROXIMITY 0d<=7dInsider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
57 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $77.05Resistance $91.07

Price Targets

$66
$73
$89
A.Upside+1.7%
A.R:R-0.6:1
Setup A.R:R (at entry)2.7:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (-7.7% upside)
! Earnings in 0 days - binary event risk
! Momentum score 3.6/10 — below 4.5 minimum

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-04-30 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ITGR stock a buy right now?

Wait for pullback to $72.55. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $87.78. Engine's entry $72.55 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Value-trap signals (3/5): Revenue declining (-89.9% YoY), Margin compression (op margin -6710.7%), Negative free cash flow. Chart setup: RSI 57 mid-range, Bollinger mid-band. Earnings in 0 days. Wait until post-earnings. Target $89.25 (+1.7%), stop $66.05 (−32.9%), Setup A.R:R 2.7:1. Score 5.2/10, moderate confidence.

What is the ITGR stock price target?

Take-profit target: $89.25 (+13.4% upside). Target $89.25 (+1.7%), stop $66.05 (−32.9%), Setup A.R:R 2.7:1. Stop-loss: $66.05.

What are the risks of investing in ITGR?

Analyst target reached - limited upside remaining; Value-trap signals (3/5): Revenue declining (-89.9% YoY), Margin compression (op margin -6710.7%), Negative free cash flow.

Is ITGR overvalued or undervalued?

Integer Holdings Corporation trades at a P/E of 29.0 (forward 11.6). TrendMatrix value score: 6.3/10. Verdict: Buy (Wait for Entry).

What do analysts say about ITGR?

17 analysts cover ITGR with a consensus score of 3.7/5. Average price target: $93.

What does Integer Holdings Corporation do?Integer Holdings is a leading medical device CDMO serving Cardio & Vascular, Neuromodulation, and Cardiac Rhythm...

Integer Holdings is a leading medical device CDMO serving Cardio & Vascular, Neuromodulation, and Cardiac Rhythm Management markets under the Greatbatch Medical and Lake Region Medical brands. It sells components, subassemblies, and finished devices primarily to large multinational OEM customers.

Related stocks: GMED (Globus Medical, Inc.) · TMDX (TransMedics Group, Inc.) · DXCM (DexCom, Inc.) · ATEC (Alphatec Holdings, Inc.) · HAE (Haemonetics Corporation)